Relmada Therapeutics, Inc. (RLMD)
3.26
-0.02
(-0.61%)
USD |
NASDAQ |
Oct 07, 16:00
3.26
0.00 (0.00%)
After-Hours: 20:00
Relmada Therapeutics Price : 3.26 for Oct. 7, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 06, 2026 | 3.50 | 3.50 | 3.265 | 3.28 | 1.736M |
| Oct 05, 2026 | 3.60 | 3.70 | 3.415 | 3.48 | 1.283M |
| Oct 02, 2026 | 3.72 | 3.73 | 3.60 | 3.60 | 1.210M |
| Oct 01, 2026 | 3.73 | 3.80 | 3.65 | 3.66 | 1.358M |
| Sep 30, 2026 | 3.78 | 3.845 | 3.72 | 3.77 | 999526.0 |
| Sep 29, 2026 | 3.82 | 3.89 | 3.695 | 3.73 | 863546.0 |
| Sep 28, 2026 | 3.80 | 3.855 | 3.71 | 3.79 | 986629.0 |
| Sep 25, 2026 | 3.81 | 3.87 | 3.73 | 3.83 | 1.311M |
| Sep 24, 2026 | 3.74 | 3.875 | 3.66 | 3.81 | 1.325M |
| Sep 23, 2026 | 4.26 | 4.26 | 3.77 | 3.78 | 1.130M |
| Sep 22, 2026 | 4.16 | 4.27 | 4.145 | 4.24 | 662655.0 |
| Sep 21, 2026 | 4.13 | 4.235 | 4.075 | 4.16 | 552734.0 |
| Sep 18, 2026 | 4.15 | 4.17 | 4.06 | 4.12 | 2.070M |
| Sep 17, 2026 | 4.28 | 4.39 | 4.18 | 4.20 | 772911.0 |
| Sep 16, 2026 | 4.45 | 4.572 | 4.205 | 4.22 | 824376.0 |
| Sep 15, 2026 | 4.44 | 4.495 | 4.30 | 4.44 | 1.999M |
| Sep 14, 2026 | 4.52 | 4.56 | 4.42 | 4.44 | 1.265M |
| Sep 11, 2026 | 4.60 | 4.65 | 4.295 | 4.52 | 2.629M |
| Sep 10, 2026 | 4.25 | 4.25 | 4.00 | 4.07 | 2.809M |
| Sep 09, 2026 | 4.24 | 4.28 | 4.09 | 4.09 | 1.590M |
| Sep 08, 2026 | 4.40 | 4.425 | 4.13 | 4.25 | 1.698M |
| Sep 04, 2026 | 4.35 | 4.44 | 4.32 | 4.43 | 675556.0 |
| Sep 03, 2026 | 4.55 | 4.58 | 4.33 | 4.37 | 847511.0 |
| Sep 02, 2026 | 4.54 | 4.593 | 4.365 | 4.54 | 1.417M |
| Sep 01, 2026 | 4.31 | 4.51 | 4.31 | 4.46 | 944057.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ANI Pharmaceuticals, Inc. | 71.80 |
| Corcept Therapeutics, Inc. | 119.59 |
| Veru, Inc. | 2.47 |
| Johnson & Johnson | 258.37 |
| Eli Lilly & Co. | 1188.50 |
Price Related Metrics
| Price to Book Value | 1.683 |
| Earnings Yield | -28.53% |
| Market Cap | 347.74M |